Journal of Global Pharma Technology
Volume 9 Issue 10

The Relation of Angiotensin Converting Enzyme-1 Gene with Angiotensin II and Plasminogen Activator Inhibitor in Myocardial Infarction

Maha F. Smaism (Unknown)



Article Info

Publish Date
27 Nov 2017

Abstract

One of the very important causes of mortality worldwide is myocardial infarction (MI). Angiotensin converting enzyme-1 (ACE-1) gene plays a principal role in converting of angiotensin-I (ANG I) to angiotensin II (ANG II).  ANG II plays necessary role in promoting of hypertension, furthermore due to the improvement of cardiovascular disease, myocardial infarction. Plasminogen activator inhibitor-1(PAI-1) play a function in modulating intravascular thrombosis, impaired fibrinolytic linked to a high level of  (PAI-1).The aim of the study is to evaluate the role of ACE-1polymorphism in level of ANG II, and the relation between plasminogen activator inhibitor-1concentration and ANG II in (MI) and hypertension patients. The study includes (100) males: 25 control, 75 patient groups, the patient group subdivided into {25  hypertensive patients for 10 years (group A), 25 hypertensive patients for 20 years(group B), 25 patients with MI+ hypertension ( group C)}, ages between (50-60 years) and BMI (18.5-24.9).The results show: There is significantly increased of ANG II, PAI-1, TG, Total cholesterol(TC), LDL-c and VLDL-c concentration, while significantly decreased of serum HDL-c in all groups of patients compared with the control group. The result observed significantly increase of ACE-1 deletion –deletion (DD)in  group  (C)  (88%) compared with the control group (44%), while there were no significantly increased in groups (A,B) compared with control group, also the result showed ACE-1 (DD) genotype was (66%), insertion-deletion (ID) genotype was (34%) and ACE insertion-insertion( II )genotype was (0%) in all study groups. And there was a positive correlation between angiotensin II and plasminogen activator inhibitor-1 in all patient groups. Conclusion: The (DD) genotype of the Angiotensin converting enzyme-1 (ACE-1) polymorphism was the most frequent among Babylon patients with myocardial infarction. This suggests that Babylon individuals with the (DD) genotype might be at high risk for myocardial infarction .Furthermore, D allele of the ACE I polymorphism might confer increased risk for MI. plasminogen activator inhibitor 1(PAI-1) may consider as a risk factor of myocardial infarction. And there was a positive correlation between angiotensin II and plasminogen activator inhibitor-1 in all patient groups. Therefore DD genotype be lead to an increase of PAI-1level.Keywords: Myocardial infarction, Angiotensin converting enzyme-1, Plasminogen activator inhibitor-1, Angiotensin II.

Copyrights © 2017






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...